多瑞医药：8月26日召开董事会会议

Group 1 - The core viewpoint of the article highlights the announcement by Duori Pharmaceutical regarding its board meeting and the composition of its revenue for the year 2024 [1] - Duori Pharmaceutical's revenue composition for 2024 indicates that the pharmaceutical manufacturing sector accounts for 57.85% while other sectors contribute 42.15% [1] - As of the report, Duori Pharmaceutical has a market capitalization of 3.3 billion yuan [1] Group 2 - The article also mentions the booming pet industry, valued at 300 billion yuan, and the positive market response from listed companies in this sector [1]